May 13th, 2021
Speciality pharmacist and patient advocate, Michael Rigas, PharmD, will continue to dive deeper into discussion topics regarding IVIG/SCIG issues that were not covered in Part I of this educational webinar series
Dr. Rigas will discuss the following:
- Discuss the physician referral and onboarding process with an IVIG pharmacy company
- Discuss how to make IVIG more affordable for the patient
- Discuss the economics of IVIG in the eyes of the FDA, the drug maker and the insurance company
- Discuss how to maximize the Clinical outcome and your experience with IVIG
Dr. Rigas is the Chief Clinical Officer, co-founder and principal at KabaFusion, an infusion therapy company dedicated to managing IVIG and other chronic and acute therapies nationwide. Prior to joining KabaFusion, Dr. Rigas was Associate Chief Innovation Officer for Pharmaceutical Care for Geisinger Health System and Chief Clinical Officer for VITALine CareSite Pharmacy Services.
Dr. Rigas graduated from USC School of Pharmacy with his Pharm.D. degree and completed his residency at UC San Francisco Hospitals and Clinics in 1982. His areas of expertise include antimicrobial therapy, immunoglobulin therapies (IVIG), nutritional support, inotropic therapies and many others.
Over the last 20 years, Dr. Rigas has managed or overseen the care of over 15,000 patients who have received over 20,000,000 grams of IVIG.
This presentation is an open forum event. Attendees can interact with Dr. Rigas and ask any questions they may have. This webinar will also be recorded live on May 13th and made available as a resource for patients on the AAIDA website soon after.